View source for Valerii Shapovalov

<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Valerii Shapovalov|English]] · [[Valerii Shapovalov/uk|Українська]] · [[Valerii Shapovalov/es|Español]] · [[Valerii Shapovalov/fr|Français]] · [[Valerii Shapovalov/de|Deutsch]] · [[Valerii Shapovalov/pt|Português]]</div>
'''Valerii Shapovalov''' is a contributor to the publications documented in this wiki. Also appears as Valeriy Shapovalov; Ukrainian name (original script): Шаповалов Валерій Володимирович. He is distinct from [[Valentyn Shapovalov]].

== Identity and public profiles ==
* [https://orcid.org/0000-0002-6696-6380 ORCID 0000-0002-6696-6380].
* [https://www.researchgate.net/profile/Valeriy-Shapovalov ResearchGate profile].
* [https://scholar.google.com.ua/citations?user=ApyTr_oAAAAJ&hl=en Google Scholar profile], linked from the [https://apmplmi.com/index.php/apmp/about/editorialTeam editorial directory].

== Dated institutional context ==
The SRUMPL management page, dated 16 May 2026, identifies him as honorary president and associates him with the forensic and pharmaceutical sector. The September 2025 drug-policy paper lists Lviv Medical University as his affiliation; these records describe different contexts and dates.

[https://srumpl.org/ena/Management.html SRUMPL management record] and the specific publications below provide the source context.

== Selected publication connections ==
* With Andriy Gudzenko, Valentyn Shapovalov and Viktoriya Shapovalova: the 2021 forensic-pharmacy complaints study, DOI [https://doi.org/10.31435/rsglobal_sr/30042021/7517 10.31435/rsglobal_sr/30042021/7517].
* With Ivan Voloshyn-Haponov, Andrii Diachenko and Natalia Matsko: a 2025 editorial on illicit psychoactive-substance trafficking, mental public health and rehabilitation, [https://ssp.sreif.us/index.php/mlp/article/view/6 publisher record]. An editorial's proposals are not equivalent to demonstrated clinical outcomes.
* With Oleksandr Veits, Olena Lavoshnyk and Olga Gubaryeva: vaccine-circulation governance and pharmaceutical administration (26 July 2025), [https://ssp.sreif.us/index.php/mespa/article/view/9 publisher record].

== Shared conceptual publications ==
The publisher records list this author among the six coauthors of [[The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration]] (12 December 2025) and [[Vision 2035|Vision 2035 – Medico-Pharmaceutical Law for Human Security]] (6 March 2026). These bylines apply to those editions, not automatically to every later revision or conceptual article.

* [https://books.sreif.us/index.php/sreif/catalog/book/10 2025 monograph], DOI 10.53933/3qgntf55.
* [https://books.sreif.us/index.php/sreif/catalog/book/13 2026 book], DOI 10.53933/b91avw28.

== Reading the record ==
Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See [[Research network]] for dated, work-specific connections and [[People and attribution]] for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.
[[Category:People]]

== Public research records before 2021 ==
The selected public records include counterfeit-medical-product conventions and information systems (2013), rural pharmacy sustainability (2014), chronic-pain provision (2015) and FDA-related comparative regulation (2016). See [[ORCID bibliography before 2021]] for the individual public work links and [[Research before 2021]] for publisher-grounded descriptions. These are bibliographic topic descriptions, not a claim of sole authorship or full-text review of every work.

Source: [https://orcid.org/0000-0002-6696-6380 public ORCID profile] and the exact work records linked in the guide.